Colleen Moretti
Articles
Study Seeks to Identify Connection Between Cognitive function and Anxiety In Patients Receiving Chemotherapy
May 10, 2022
Article
Unrelieved stress may contribute to cancer-related cognitive impairment and anxiety in patients undergoing chemotherapy.
Following ADT, Older Patients With Prostate Cancer Are at an Increased Risk of Cardiac Complications
May 08, 2022
Article
Older men who have received androgen-deprivation therapy are an increased risk of heart issues, however, the root of the risk is still not well understood.
Cancer Survivors Struggling With Insomnia May Benefit from Cognitive Therapy
May 07, 2022
Article
Cognitive therapies were found to be effective for helping cancer survivors with insomnia, but more research is needed for patients actively receiving treatment.
Cabozantinib Validated as Safe Post-Immunotherapy Option for Patients with mRCC
February 24, 2022
Article
Cabozantinib is determined to be a safe treatment option for patients with metastatic renal cell carcinoma whose disease failed to respond to prior immunotherapy combinations.
High BMI in Localized Prostate Cancer Associated With Decreased Likelihood of Undergoing Surgery
December 07, 2021
Article
Researchers identified a linear decrease in the likelihood of surgery once patients with localized prostate cancer reached a BMI of 33 or greater.
Rates of Upgrading, Adverse Pathology Similar in Hispanic and White Non-Hispanic Men With Prostate Cancer
December 06, 2021
Article
Hispanics are the largest ethnic minority and one of the most rapidly growing populations in the United States. Prostate cancer represents the highest incident non-cutaneous malignancy in this population.
Yoga Encourages Antitumor Response, Boosts Quality of Life in Patients with Prostate Cancer
September 16, 2021
Article
Yoga has a positive impact on the vagus nerve, which influences how people think, remember, and feel, and therefore can improve the mental well-being of patients with prostate cancer.
Retevmo Shows Improvement for Previously Treated Patients With Non-Small Cell Lung Cancer
June 06, 2021
Article
Previously treated patients with non-small cell lung cancer tended to have better responses with Retevmo than they did with prior treatments.
Pralsetinib Is Tolerable, Durable in RET Fusion+ NSCLC
June 04, 2021
Article
Pralsetinib elicited promising responses and tolerability in patients with RET fusion-positive non-small cell lung cancer (NSCLC), including those who were not eligible for platinum-based therapy.
COVID-19 Pandemic Shows ‘Silver Lining’ of Virtual Visits for Veterans Who Have Survived Cancer
April 26, 2021
Article
Due to the COVID-19 pandemic, many patients’ and survivors’ care has changed, but one nurse and her team sought to make this population more comfortable and safe during these times with virtual visits.